Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Trials"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Hobbs%2C+Fd+Richard%22&type=Person&filter%5B%5D=journalStr%3A%22Trials%22
/vufind/Search/Results?lookfor=%22Hobbs%2C+Fd+Richard%22&type=Person&filter%5B%5D=journalStr%3A%22Trials%22
Search /vufind/Search2/Results?lookfor=%22Hobbs%2C+Fd+Richard%22&type=Person&filter%5B%5D=journalStr%3A%22Trials%22
PubPharm (3)
1
Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone : study protocol for a randomized controlled trial
enthalten in:
Trials
| 2014
von
Hill, N.
|
Lasserson, D.
|
Thompson, B.
| +13
ErratumIn: Trials. 2022 Dec 12;23(1):999. - PMID 36510220
Wird geladen...
2
Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial
enthalten in:
Trials
| 2014
von
Hill, N.
|
Lasserson, D.
|
Thompson, B.
| +13
Wird geladen...
3
Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial
enthalten in:
Trials
| 2014
von
Hill, N.
|
Lasserson, D.
|
Thompson, B.
| +13
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Trials
Medienart
3
Aufsätze
3
E-Artikel
3
E-Ressourcen
Zeitschriftentitel
Trials
Thema
2
CKD aldosterone receptor antagonist
2
CKD mortality
2
Cardiovascular disease
2
Chronic kidney disease
1
27O7W4T232
1
Journal Article
1
Mineralocorticoid Receptor Antagonists
1
Multicenter Study
1
Randomized Controlled Trial
1
Research Support, Non-U.S. Gov't
1
Spironolactone
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3
Englisch
Haven't found what you're looking for?
Wird geladen...